Senior counselor | Pfizer & Novartis | October 2013 – May 2014 (8 months)

Developing an approach and commitment to a decentralised organisation for costing specialist drugs in cooperation with professional associations, healthcare

Process manager sectoral agreements Imnovid (pomalidomide) | Celgene | May 2014 – Present (8 months)

Process management and consultancy for the Round Table Discussion between participants HOVON, Celgene, Achmea, Menzis, Multizorg VRZ, CZ, VGZ and hospitals. The

Ext. project director advanced parkinson breakthrough | AbbVie | June 2014 – Present (7 months)

Development and pilot testing of a regional care concept for advanced parkinson patients in cooperation with hospitals and nursing homes. Ambition: reducing

Program-management repositioning Lucentis | Novartis Farma | 2011-2012

repositioning Lucentis (30 million) because of the inclusion in national directives of the company’s competitor Avastin

Economic impact of health care procurement influenced by market liberalization | ONVZ |

consulting cases and funding, health care procurement

Business case pharmaceutics procurement | Multizorg |

consulting business development, cases and funding, health care procurement sector: health care insurers, pharmaceutics and life sciences companies

Extending the collaboration for the purposes of health care procurement in order to include VRZ verzekeraars | Multizorg VRZ |

Achieving synergy and collaboration, health care procurement, health care insurers

Business case of a merger between a general insurer and a health care insurer | Goudse/Trias |

Achieving synergy and collaboration, health care insurers

Strategy reconnaissance for a pharmacy chain | Lloyds |

Strategy & governance, health care providers

View on outsourcing | OPG |

Strategy & governance, health care providers

Supporting a British venture capital fund in finding investment opportunities in the Netherlands | Medicsight |

Business development, cases and funding, health care providers

Strategic scenario analysis, assessing five-year plans | RvB/RvT Parnassia |

Strategy & governance, health care providers

Strategic reorientation on the future | Slotervaart Ziekenhuis |

Achieving synergy and collaboration, health care providers

Measurement instrument for health care insurers and the health care industry | Consumentenbond |

Interest groups

Developing the Medicijnwijzer.nl website | patientenorganisatie in de GGZ |

Interest groups, patients

Feasibility of clustering the legal support provided by patient interest groups | CG Raad |

Interest groups, health care providers

Position paper on corporate governance in health care | NVZ, Actiz, VGN, GGZ Nederland |

Strategy & governance, interest groups, health care providers

Strategy, tactics and system of introducing free physiotherapy pricing | KNGF |

Convincing industry lobby, interest groups, health care providers

Outlook and lobby approach for independent psychiatrists | NVVP |

Convincing industry lobby, interest groups, health care providers

Strategy for introducing DBC funding in psychological health care | GGZ Nederland |

Convincing industry lobby, interest groups, health care providers

Second opinion on BCG report on bonuses and pharmaceutics discounts | KNMP |

Convincing industry lobby, interest groups, pharmaceutics and life sciences companies

Organiseren van inkoopmacht van chronisch zieken | ZonMw |

Verantwoorde liberalisatie in de zorg, samenwerking & synergie  realiseren, business development, cases & bekostiging, zorginkoop aan zet, overheid,

Analysis of the potential for market liberalization in seven paramedic professions. | VWS |

Analysis of the potential for market liberalization in seven paramedic professions: physiotherapy, dentistry, speech therapy, occupational therapy, obstetrics,

The effects of scaling up in psychological health care | CVZ |

Responsible health care liberalization, achieving synergy and collaboration, authorities, health care providers

IBO report ‘Concentratie en samenwerking in de gezondheidszorg’ | Ministeries of General Affairs, Finance, Health Care and Scienc; College voor Zorgverzekeringen, RVZ, ZONMw |

Responsible health care liberalization, achieving synergy and collaboration, authorities

Advice on the improvement of the commercial position of Pico (complex wound therapy / negative pressure therapy) | Smith&Nephew | 2013

Advice on an effective commercial approach for new line of products in complex wound therapy

Management team member at IZZ Zorgverzekeringen | VGZ / IZZ Zorgverzekeringen | 2006 - 2007

Strategy, decoupling UVIT’s front office, setting up a new organization structure, realizing policy sales growth, launching new services

Management team member at ACHMEA Zorginkoop | Achmea | 2008

Primary health care procurement plan 2009/10, reorganization, adapting membership of the company’s management team

Director of business development TNF Care | MSD Nederland B.V. | 2010 – 2011

pay-for-performance Remicade (100 mio) incl. ontwikkeling infusie scorecard, pilots Atruim en RdGG en uitrol naar 25 ziekenhuizen.

Project lead Novartis Pharma | Novartis Pharma | 2011 - 2012

Crisismanagement Lucentis (30 mio). Developing strategic plan for Lucentis (eye-care) and support Novartis in execution

Programme management accountability and funding of specialist medicines | Novartis & Pfizer |

Pharmaceutics and life sciences companies

Programme management for the extension of intramural and extramural services | Farminform | 2012 - onderhanden

Pharmaceutics and life sciences companies, convincing industry lobby

Programme mangement commercial breakthrough Specialty Care / Global pilot ESAT Pfizer | Pfizer | 2012 - 2013

commercial breakthrough project innovative pricing Enbrel (160 mio)

Business plan for a nation-wide evaluation of the distribution of expensive medicines | CVZ |

assignment type: business development, cases and funding, responsible health care liberalization, convincing industry lobby, health care